Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NSC
|
Alan H. Shaw |
SELL
Open market or private sale
|
Indirect | 43 Reduced 84.31% |
$9,176
$213.39 p/Share
|
Oct 02
2020 |
|
WERN
|
Craig T Callahan
Exec VP-Chief Commercial Offcr |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.51% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
James Lynn Johnson
Exec VP - Chief Acctg Officer |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.19% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
Derek J Leathers
CEO & Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.05% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
Nathan J Meisgeier
President and CLO |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.61% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
H Marty Nordlund
Exec VP Strategic Partnerships |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.21% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
Jim S Schelble
Exec VP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 0.24% |
$5,989
$42.78 p/Share
|
Oct 02
2020 |
|
WERN
|
John J Steele
Exec VP - Treasurer & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 105 Added 0.15% |
$4,492
$42.78 p/Share
|
Oct 02
2020 |
|
AIR
|
David P Storch
Director |
BUY
Bona fide gift
|
Indirect | 250,000 Added 48.19% |
-
|
Oct 02
2020 |
|
AIR
|
David P Storch
Director |
SELL
Bona fide gift
|
Direct | 250,000 Reduced 50.36% |
-
|
Oct 02
2020 |
|
PENN
|
David A Handler |
SELL
Bona fide gift
|
Direct | 5,000 Reduced 2.23% |
-
|
Oct 02
2020 |
|
AMIH
|
Esteban Alexander
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 7,000,000 Reduced 77.78% |
-
|
Oct 02
2020 |
|
AMIH
|
Jacob D. Cohen
Director |
BUY
Open market or private purchase
|
Indirect | 11,000,000 Added 23.55% |
-
|
Oct 02
2020 |
|
AMIH
|
Luis Alan Hernandez
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 4,000,000 Reduced 66.67% |
-
|
Oct 02
2020 |
|
BBWI
|
Leslie H. Wexner |
SELL
Bona fide gift
|
Indirect | 1,372,664 Reduced 18.34% |
-
|
Oct 02
2020 |
|
CVLG
|
David Ray Parker
Chairman and CEO |
SELL
Bona fide gift
|
Direct | 100,000 Reduced 4.38% |
-
|
Oct 02
2020 |
|
SRI
|
Jonathan B De Gaynor
President and CEO |
SELL
Bona fide gift
|
Direct | 5,000 Reduced 2.69% |
-
|
Oct 02
2020 |
|
GMBL
|
Chul Woong Lim
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,113 Added 45.08% |
-
|
Oct 02
2020 |
|
GMBL
|
Alan Alden
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,762 Added 50.0% |
-
|
Oct 02
2020 |
|
PTON
|
John Paul Foley
Executive Chair |
SELL
Conversion of derivative security
|
Direct | 300,000 Reduced 50.0% |
-
|
Oct 02
2020 |
|
PEBO
|
John C. Rogers
Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct | 7,623 Reduced 43.04% |
-
|
Oct 02
2020 |
|
DYNT
|
Stuart Essig
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,333 Added 10.11% |
-
|
Oct 02
2020 |
|
DYNT
|
Stuart Essig
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 91,341 Added 6.22% |
-
|
Oct 02
2020 |
|
DYNT
|
Erin S. Enright
Director |
BUY
Open market or private purchase
|
Indirect | 109,674 Added 8.16% |
-
|
Oct 02
2020 |
|
DYNT
|
Brian Larkin
Director |
BUY
Open market or private purchase
|
Direct | 5,449 Added 3.11% |
-
|
Oct 02
2020 |
|
DYNT
|
Provco Ventures 1 LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 54,806 Added 5.66% |
-
|
Oct 02
2020 |
|
DYNT
|
Brian D. Baker
CEO & President |
BUY
Open market or private purchase
|
Direct | 7,692 Added 100.0% |
-
|
Oct 02
2020 |
|
PCSA
|
James E Besser |
BUY
Open market or private purchase
|
Direct | 30,000 Added 6.9% |
$121,200
$4.04 p/Share
|
Oct 02
2020 |
|
HCAT
|
D Fraser Bullock |
SELL
Open market or private sale
|
Direct | 1,700 Reduced 2.46% |
$62,917
$37.01 p/Share
|
Oct 02
2020 |
|
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.23% |
$18,505
$37.01 p/Share
|
Oct 02
2020 |
|
HCAT
|
Daniel H. Orenstein
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 500 Added 1.22% |
$5,170
$10.34 p/Share
|
Oct 02
2020 |
|
CRVL
|
V Gordon Clemons |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.14% |
$87,200
$87.2 p/Share
|
Oct 02
2020 |
|
LSCC
|
Sherri R Luther
SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,376 Reduced 4.67% |
$123,491
$28.22 p/Share
|
Oct 02
2020 |
|
LSCC
|
Sherri R Luther
SVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 8,824 Added 8.6% |
-
|
Oct 02
2020 |
|
SNX
|
Kevin M Murai
Director |
SELL
Bona fide gift
|
Indirect | 1,390 Reduced 1.0% |
-
|
Oct 02
2020 |
|
EPAY
|
Richard Douglas Booth
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 0.98% |
$46,354
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
Norman J Deluca
MD of Banking Solutions |
SELL
Open market or private sale
|
Direct | 870 Reduced 0.91% |
$36,662
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
Robert A Eberle
President & CEO |
SELL
Open market or private sale
|
Direct | 5,209 Reduced 1.13% |
$219,507
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
John Francis Kelly
GM, Legal Solutions |
SELL
Open market or private sale
|
Direct | 326 Reduced 0.53% |
$13,738
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
Nigel K Savory
Managing Director Europe |
SELL
Open market or private sale
|
Direct | 1,442 Reduced 0.88% |
$60,766
$42.14 p/Share
|
Oct 02
2020 |
|
LOVE
|
Shirley Romig
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,868 Added 50.0% |
-
|
Oct 02
2020 |
|
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct | 4,667 Reduced 10.66% |
$1,306,760
$280.0 p/Share
|
Oct 02
2020 |
|
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct | 4,667 Added 9.64% |
$443,878
$95.11 p/Share
|
Oct 02
2020 |
|
ICD
|
John A. Gallegos Jr.
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 956 Reduced 3.13% |
-
|
Oct 02
2020 |
|
ICD
|
John A. Gallegos Jr.
PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,929 Added 11.41% |
-
|
Oct 02
2020 |
|
ICD
|
James Minmier |
BUY
Exercise of conversion of derivative security
|
Direct | 353 Added 7.08% |
-
|
Oct 02
2020 |
|
AINC
|
Monty J Bennett
CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct | 4,430 Added 4.03% |
-
|
Oct 02
2020 |
|
HOOK
|
Capital Vi Fcpr Sofinnova
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.01% |
$3,000
$10.0 p/Share
|
Oct 02
2020 |
|
HGBL
|
Topline Capital Partners, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 848,937 Added 16.3% |
$1,519,597
$1.79 p/Share
|
Oct 02
2020 |
|
HGBL
|
Topline Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 848,937 Added 8.38% |
$1,519,597
$1.79 p/Share
|
Oct 02
2020 |